Letter to the editor: switching treatment to lamivudine plus boosted atazanavir or darunavir in virologically suppressed HIV-infected patients - evidence from a large observational cohort.
Davide Fiore BavaroD Di CarloP ZuccalàF BaiF IncardonaA BattistiS GiachèE SalomoniR GagliardiniS Di GiambenedettoM PecorariM ZazziA De LucaA BezenchekS Lo CaputoPublished in: Infectious diseases (London, England) (2019)